Literature DB >> 8359712

Current status of antioxidant therapy.

C A Rice-Evans1, A T Diplock.   

Abstract

There is evidence that free radical damage contributes to the aetiology of many chronic health problems such as emphysema, cardiovascular and inflammatory diseases, cataracts, and cancer. In this review we are not concerned with tissue damage in vivo induced directly by radicals from exogenous sources, such as air pollutants and tobacco smoke, high-pressure oxygen, irradiation, or through the metabolism of certain solvents, drugs, and pesticides. Rather, we address some of the disease states associated with increased oxidative stress from endogenous sources and the possible therapeutic advantage of the antioxidant treatment. This raises the question of the antioxidant status of individuals and its role in protection against amplification of certain disease processes. We have chosen to concentrate mainly on coronary heart disease, reperfusion injury, and organ storage for transplantation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359712     DOI: 10.1016/0891-5849(93)90127-g

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  26 in total

1.  Antioxidant therapy attenuates oxidative stress in the blood of subjects exposed to occupational airborne contamination from coal mining extraction and incineration of hospital residues.

Authors:  D Wilhelm Filho; S Avila; F P Possamai; E B Parisotto; A M Moratelli; T R Garlet; D B Inácio; M A Torres; P Colepicolo; F Dal-Pizzol
Journal:  Ecotoxicology       Date:  2010-06-10       Impact factor: 2.823

2.  Efficacy of edaravone on coronary artery bypass patients with myocardial damage after ischemia and reperfusion: a meta analysis.

Authors:  Chenhong Zheng; Shouying Liu; Peiliang Geng; Huiming Zhang; Hongpeng Zhang; Airong Tang; Xiaohua Xie
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Chitosan gallate as a novel potential polysaccharide antioxidant: an EPR study.

Authors:  Wanvimol Pasanphan; Garry R Buettner; Suwabun Chirachanchai
Journal:  Carbohydr Res       Date:  2009-10-02       Impact factor: 2.104

4.  Reconvene and reconnect the antioxidant hypothesis in human health and disease.

Authors:  P P Singh; Anu Chandra; Farzana Mahdi; Ajanta Roy; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2010-09-03

5.  Soluble recombinant neutral endopeptidase (CD10) as a potential antiinflammatory agent.

Authors:  N J Solan; P E Ward; S P Sanders; M C Towns; J M Bathon
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

6.  Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.

Authors:  L Iuliano; A R Colavita; C Camastra; V Bello; C Quintarelli; M Alessandroni; F Piovella; F Violi
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Antioxidant enzymes in the human iris: an immunogold study.

Authors:  G E Marshall
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

Review 8.  Prospects for the use of antioxidant therapies.

Authors:  S R Maxwell
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

Review 9.  New approaches to the prevention of atherosclerosis.

Authors:  M Naito; T Hayashi; A Iguchi
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

10.  Prospects for redox-based therapy in neurodegenerative diseases.

Authors:  A L Friedlich; M F Beal
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.